Ben Tre Pharmaceutical JSC (HOSE:DBT)

Market Cap	252.63B
Revenue (ttm)	863.36B
Net Income (ttm)	17.52B
Shares Out	21.97M
EPS (ttm)	797.14
PE Ratio	14.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	934
Average Volume	22,200
Open	11,700
Previous Close	10,950
Day's Range	11,500 - 11,700
52-Week Range	9,907 - 12,664
Beta	0.51
RSI	51.04
Earnings Date	Oct 30, 2025

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 774
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2024, HOSE:DBT's revenue was 868.41 billion, an increase of 7.00% compared to the previous year's 811.62 billion. Earnings were 13.49 billion, an increase of 4.02%.